3Nakao S ,Takamatsu H,Chuhjo T, et al. Identification of a specific haplotypo strongly associated with susceptibility to cyclosporine-HLA class P dependent aplastic anemia[J]. Blood,1994,84(12) :4 257-4 261.
4Maciejewski JP, Hibbs JR, Anderson S, et al. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure[J]. Exp Hematol, 1994, 22: 1 102 - 1110.
5Hsu HC,Tsa WH,Che LY,et al. Overproduction of in hibitory haematopoietic cytodines by lipopolysaccharide-activated peripheral blood mononuclear cells in patients with aplastic anemia[J]. Ann Heamatol,1995,71:281
6Yougn NS, Barreyy AJ. The treatment of severe acquired aplastic anemia[J]. Blood,1995,85:3 367.
7Tong J, Bacigalugo A, Piaggio G, et al. Severe aplastic anemia (SAA) : response to cyclosporin A(CYA)in vivo and in vitro[J]. Eur Haematol, 1991,46(4) :212-216.
8张之南主编.血液学诊断及疗效标准.第2版.北京:科学出版社,1998.33-38.
9Nakao S,Yamaguchi M,Shintaro S,et al.Interferon γgene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia.Blood,1992,79(10):2532-2535.
10Gottwald E,Muller O,Polten A.Semiquantitative reverse transcriptionpolymerase chain reaction with the Agilent 2100 Bioanalyzer.Electrophoresis,2001,22(18):40164022.
